The aberrant activation of signaling cascades mediated by insulin and the insulin-like growth factor (IGF) family has been implicated in the pathophysiology of numerous ailments, including diabetes, cancer, obesity, neurodegenerative disorders, and musculoskeletal conditions (30–33). Here, IGF1 is linked to obesity disorder.